Thymus Extract - Tremfya (Guselkumab) Interaction

Interaction Details

Guselkumab is classified as belonging to the following category: Immunosuppressants

Theoretically, patients taking immunosuppressants may be at an increased risk of infection from contaminated thymus extract.
Thymus extract is derived from raw bovine thymus glands and is at risk for contamination. Tell patients to avoid thymus extract products unless these products are certified as pathogen-free.

Interaction Rating

Likelihood of Occurrence

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists

References

• Lewis CJ. Letter to reiterate certain public health and safety concerns to firms manufacturing or importing dietary supplements that contain specific bovine tissues. FDA. Available at: www.cfsan.fda.gov/~dms/dspltr05.html.

Guselkumab Overview

• Guselkumab injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in adults whose psoriasis is too severe to be treated by topical medications alone. It is also used alone or in combination with other medications to treat psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin) in adults. Guselkumab injection is in a class of medications called monoclonal antibodies. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis.

Thymus Extract - More Interactions

Thymus Extract interacts with 112 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.